Contemporary management of malignant mesothelioma

P. Baas (Amsterdam, The Netherlands)

Source: Annual Congress 2004 - PG20 - State-of-the art in management of pleural diseases

Session: PG20 - State-of-the art in management of pleural diseases
Session type: Postgraduate Course
Number: 67

Disease area: Thoracic oncology

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Baas (Amsterdam, The Netherlands). Contemporary management of malignant mesothelioma. Annual Congress 2004 - PG20 - State-of-the art in management of pleural diseases

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Management of malignant mesothelioma Source: ERS Skills Course 2018 - Practical Pleural Skills Year: 2018
Multimodal management of malignant pleural mesothelioma: where are we today? Source: Eur Respir J 2014; 44: 754-764 Year: 2014
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma Source: Guideline 2020 Year: 2020
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma Source: Eur Respir J, 55 (6) 1900953; 10.1183/13993003.00953-2019 Year: 2020
Management of malignant pleural mesothelioma Source: ERS Skills Course 2015 Year: 2015
Management of malignant pleural mesothelioma Source: Hands-on Course 2012 - Medical Thoracoscopy Year: 2012
Management of malignant pleural mesothelioma Source: School Course 2014 - Medical Thoracoscopy Year: 2014
Management of malignant pleural mesothelioma Source: Hands-on Course 2013 - Medical Thoracoscopy Year: 2013
Management of malignant pleural mesothelioma Source: ERS Course 2016 - Skills course on medical thoracoscopy Year: 2016
Multimodality therapy for malignant pleural mesothelioma Source: Eur Respir J 2004; 24: Suppl. 48, 526s Year: 2004
Diagnosis of malignant pleural mesothelioma Source: Eur Respir J 2004; 24: Suppl. 48, 527s Year: 2004
Treatment of malignant pleural mesothelioma: dilemmas Source: Eur Respir J 2005; 26: Suppl. 49, 73s Year: 2005
Videothoracoscopy in diagnosis and palliative treatment of malignant pleural mesothelioma Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008
Diagnosis and staging of malignant pleural mesothelioma Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020
Immunotherapy for malignant pleural mesothelioma: ready for clinical practice? Source: International Congress 2016 – Immunotherapy: the lethal weapon against thoracic malignancies? Year: 2016
Update on biology and management of mesothelioma Source: Eur Respir Rev, 30 (159) 200226; 10.1183/16000617.0226-2020 Year: 2021
Malignant pleural mesothelioma: our multimodality approach Source: Eur Respir J 2002; 20: Suppl. 38, 40s Year: 2002
Bevacizumab-targeted therapy for malignant pleural mesothelioma Source: International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs Year: 2017